<SEC-DOCUMENT>0001193125-15-242777.txt : 20150817
<SEC-HEADER>0001193125-15-242777.hdr.sgml : 20150817

<ACCEPTANCE-DATETIME>20150701140358

<PRIVATE-TO-PUBLIC>

ACCESSION NUMBER:		0001193125-15-242777

CONFORMED SUBMISSION TYPE:	CORRESP

PUBLIC DOCUMENT COUNT:		2

FILED AS OF DATE:		20150701


FILER:


	COMPANY DATA:	

		COMPANY CONFORMED NAME:			SYNOPSYS INC

		CENTRAL INDEX KEY:			0000883241

		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]

		IRS NUMBER:				561546236

		STATE OF INCORPORATION:			DE

		FISCAL YEAR END:			1031



	FILING VALUES:

		FORM TYPE:		CORRESP



	BUSINESS ADDRESS:	

		STREET 1:		690 E MIDDLEFIELD RD

		CITY:			MOUNTAIN VIEW

		STATE:			CA

		ZIP:			94043

		BUSINESS PHONE:		6505845000



	MAIL ADDRESS:	

		STREET 1:		690 E MIDDLEFIELD RD

		CITY:			MOUNTAIN VIEW

		STATE:			CA

		ZIP:			94043



</SEC-HEADER>

<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">


<IMG SRC="g98034g63l93.jpg" ALT="LOGO">
&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman">&nbsp;&nbsp;Synopsys, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman">&nbsp;&nbsp;690
East Middlefield Road</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8.5pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">&nbsp;&nbsp;Mountain&nbsp;View,&nbsp;CA&nbsp;94043-4033</FONT></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman">&nbsp;&nbsp;<B>T</B> 650.584.5000</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman">&nbsp;&nbsp;<B>F</B> 650.965.8637</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8.5pt; font-family:Times New Roman">&nbsp;&nbsp;www.synopsys.com</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">July&nbsp;1, 2015 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>VIA
EDGAR </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cecilia Blye, Chief </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Office of Global
Security Risk </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities and Exchange Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division
of Corporate Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F. Street, N.E. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C.
20549 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>RE:</B></TD>
<TD ALIGN="left" VALIGN="top"><B>&nbsp;&nbsp;Synopsys, Inc. </B></TD></TR></TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><B>&nbsp;&nbsp;Form 10-K for the Fiscal Year Ended
October&nbsp;31, 2014 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><B>&nbsp;&nbsp;Filed December&nbsp;15, 2014 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><B>&nbsp;&nbsp;File No. 0-19807 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear
Ms.&nbsp;Blye: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We respectfully submit this letter in response to comments from the staff (the &#147;<B><I>Staff</I></B>&#148;) of the Securities and
Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) received by letter dated June&nbsp;18, 2015 relating to the Annual Report on Form 10-K for the fiscal year ended October&nbsp;31, 2014 filed by Synopsys, Inc.
(&#147;<B><I>Synopsys</I></B>,&#148; &#147;we&#148; or &#147;us&#148;) with the Commission on December&nbsp;15, 2014. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For your convenience, we have
reproduced the Staff&#146;s comments in italicized, bold type and have followed each comment with our response. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><U>General </U></I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><I>1.</I></B></TD>
<TD ALIGN="left" VALIGN="top"><B><I>You discuss on your website your technological collaboration with Samsung Electronics Co., Ltd. We note a reported statement by Samsung in August 2014 that it shipped &#147;hundreds of millions&#148; of products
that incorporate your components. We are aware of publicly available information indicating that Samsung operates in Sudan and may operate in Syria. Sudan and Syria are designated as state sponsors of terrorism by the State Department and are
subject to U.S. economic sanctions and export controls. Please describe to us the nature and extent of your past, current and anticipated contacts with Sudan and Syria, if any, whether through customers or other direct or indirect arrangements. You
should describe any products, technology or services you have provided to Sudan or Syria, directly or indirectly, and any agreements, arrangements or other contacts you have had with the governments of those countries or entities they control.
</I></B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Synopsys does not pursue business activities in Sudan or Syria, directly or indirectly. We have no plans to pursue business
activities in those countries while they remain the subject of sanctions and export controls. Synopsys confirms that, to its knowledge: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Synopsys has not had, does not have, and does not anticipate having any contacts with Sudan or Syria, whether through customers or other direct or indirect arrangements; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Synopsys has not provided any products, technology, or services to Sudan or Syria, nor do we have any agreements, arrangements, or other contacts with the governments of those countries or entities they control.
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Synopsys supplies software and hardware products that are used internally by customers to design and test integrated circuits, commonly
called semiconductor chips, as well as software tools that customers use to test the quality and security of the software code they develop. We also offer intellectual property (&#147;<B><I>IP</I></B>&#148;) products, which are designs for
electronic components that customers can integrate into their larger semiconductor chip designs, rather than designing those components themselves. We also provide technical services to support our products and help our customers develop
semiconductor chips and electronic systems. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Samsung Electronics Co., Ltd. (&#147;<B><I>Samsung</I></B>&#148;) licenses software and IP products from us and
purchases our hardware products and technical services. Our sales to Samsung were made in compliance with relevant export control and sanctions regulations. Our software and hardware products are used internally by Samsung, while only our IP
products are integrated into Samsung designs as components of their larger semiconductor chip designs. Samsung ultimately uses these designs to produce integrated circuits, which it incorporates into the electronic devices it sells. Samsung does not
provide us with user information and does not order any products from us specifically for use in Sudan or Syria. We thus do not have any information indicating that our products have been used in designs that were ultimately manufactured into
products sold in those countries. In addition, our agreements with Samsung prohibit the export or re-export of any of our products or technical data outside the U.S. except as permitted by U.S. law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Synopsys conducts its business in compliance with all applicable U.S. export control laws and regulations, including embargos against countries designated by
the U.S. State Department as state sponsors of terrorism. We maintain a system of policies and controls to prevent unauthorized sales and exports of our products. Our export compliance program includes a worldwide export compliance policy, mandatory
training for all personnel, procedures for customer screening, and agreements that require compliance with applicable export control and sanctions regulations. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><I>2.</I></B></TD>
<TD ALIGN="left" VALIGN="top"><B><I>Please discuss the materiality of any contacts with Sudan and Syria you describe in response to the comment above, and whether the contacts constitute a material investment risk for your security holders. You
should address materiality in quantitative terms, including the approximate dollar amounts of any revenues, assets and liabilities associated with Sudan and Syria for the last three fiscal years and the subsequent interim period. Also, address
materiality in terms of qualitative factors that a reasonable investor would deem important in making an investment decision, including the potential impact of corporate activities upon a company&#146;s reputation and share value. Various state and
municipal governments, universities and other investors have proposed or adopted divestment or similar initiatives regarding investment in companies that do business with U.S.-designated state sponsors of terrorism. You should address the potential
impact of the investor sentiment evidenced by such actions directed toward companies that have operations associated with Sudan and Syria. </I></B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Synopsys is not aware of any contacts, material or otherwise, with Sudan or Syria. Accordingly, we do not believe there is a material investment risk for
security holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * * * </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Synopsys
acknowledges the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Synopsys is responsible for the adequacy and accuracy of the disclosure in the filing; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Synopsys may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please contact me at (650)&nbsp;584-5000 or rrunkel@synopsys.com should you have additional comments or require additional information. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;/s/ John F. Runkel, Jr.</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John F. Runkel, Jr.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">General Counsel and Corporate Secretary</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Synopsys, Inc.</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top">Trac Pham, Chief Financial Officer </TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g98034g63l93.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g98034g63l93.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  A (0# 2(  A$! Q$!_\0
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)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
